"10.1371_journal.pone.0107935","plos one","2014-09-30T00:00:00Z","Lei Ding; Conny A Gysemans; Geert Stang√©; Yves Heremans; Yixing Yuchi; Tatiana Takiishi; Hannelie Korf; Marie Chintinne; Richard D Carr; Harry Heimberg; Daniel Pipeleers; Chantal Mathieu","Laboratory of Clinical and Experimental Endocrinology, Campus Gasthuisberg O&N1, Faculty of Medicine, Katholieke Universiteit Leuven (KU LEUVEN), Leuven, Belgium; Laboratory of Diabetes Pathology and Therapy, Diabetes Research Center, Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel (VUB), Brussels, Belgium; Laboratory of Beta Cell Neogenesis (BENE), Diabetes Research Center, Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel (VUB), Brussels, Belgium; MSD A/S, Ballerup, Denmark","Conceived and designed the experiments: LD GS YH YY MC HK TT CAG DP CM. Performed the experiments: LD GS YH YY MC HK TT CAG. Analyzed the data: LD GS DP CAG CM. Contributed reagents/materials/analysis tools: RDC. Wrote the paper: LD YH RDC DP HH CAG CM. Revised the manuscript critically for important intellectual content: CAG CM. Guarantors of this work: LD CAG CM. Had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis: LD CAG CM.","Richard D. Carr owns shares in Merck Inc., (known as MSD in Europe). This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2014","09","Lei Ding","LD",12,TRUE,10,8,5,7,TRUE,TRUE,FALSE,0,NA,FALSE
